2.05Open2.05Pre Close0 Volume34 Open Interest105.00Strike Price0.00Turnover19.09%IV1.11%PremiumJul 19, 2024Expiry Date0.89Intrinsic Value100Multiplier16DDays to Expiry1.16Extrinsic Value100Contract SizeAmericanOptions Type-0.5586Delta0.0958Gamma50.79Leverage Ratio-0.0441Theta-0.0218Rho-28.37Eff Leverage0.0869Vega
ESCO Technologies Stock Discussion
In reaction to earnings/guidance:
• $Planet Labs PBC(PL.US)$ +11.3%, $Core & Main(CNM.US)$ +6.1%, $Regal Rexnord(RRX.US)$ +2% (reaffirms outlook), $Oracle(ORCL.US)$ +1.6%
Other news:
• $Akero Therapeutics(AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos(AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $Catalyst Pharmaceuticals(CPRX.US)$ +7.7...
No comment yet